PL02.09 Nintedanib + Pemetrexed/Cisplatin in Patients with Unresectable MPM: Phase III Results from the LUME-Meso Trial

• DOI: 10.1016/j.jtho.2018.08.014
• Publication Date: 2018-10-22T19:00:15Z
• Authors: G. Scagliotti; R. Gaafar; A. Nowak; T. Nakano; J. Van Meerbeeck; S. Popat; N. Vogelzang; F. Grosso; R. Aboelhassan; M. Jakopovic; G. Ceresoli; P. Taylor; F. Orlandi; D. Fennell; S. Novello; A. Scherpereel; U. Von Wangenheim; M. Kim; J. Barrueco; A. Tsao
• Keywords: Pemetrexed; Nintedanib